Olivia Cavlan

About

Olivia Cavlan MD joined LifeArc Ventures in 2025. Olivia was previously Chief Corporate Development and Strategy Officer at the UK biotechnology company Alchemab Therapeutics, which she co-founded, with responsibility for global business development, partnerships, and corporate strategy. Before Alchemab, Olivia was an Investment Principal at SV Health Investors and a Partner at McKinsey & Company, where she was part of the leadership team in the Healthcare Private Equity and Pharmaceutical practices. At McKinsey, she co-led the global Real World Evidence practice and QuantumBlack’s biopharmaceutical offering, focusing on target discovery and clinical development. She has led global biopharma R&D transformation initiatives and developed clinical and commercial strategies for preclinical and clinical assets. Olivia is a Non-Executive Director of the UK BioIndustry Association and a member of the Investment Committee for Cancer Research UK’s (CRUK) Seed fund. She co-founded and sits on th

Source (opens in a new tab)